TTrialPathMatch Me to Trials
← Back to trials
RecruitingNon-inflammatory Degenerative Joint DiseaseRhematoid ArthritisCorrection of Functional Deformity

Tornier Perform™ Reversed Monopost Study

Eligible age

18+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.

Sponsor: Stryker Trauma and Extremities

You may qualify if…

  • ✓ 18 years or older at the time of the informed consent.
  • ✓ Informed and willing to sign an informed consent form (ICF) approved by Institutional Review Board (IRB) or Ethics Committee (EC).
  • ✓ Willing and able to comply with the requirements of the study protocol
  • ✓ Considered a candidate or having received shoulder arthroplasty with the device, having a functional deltoid muscle and with massive and non-repairable rotator cuff tear with pain disabled by:
  • ✓ Rheumatoid arthritis
  • ✓ Non-inflammatory degenerative joint disease (i.e. osteoarthritis and avascular necrosis)
  • ✓ Correction of functional deformity
  • ✓ Fracture of the Humeral Head

You may not qualify if…

  • ✕ Contraindications or hypersensitivity to the use of the Tornier Perform™ Reversed MonoPost System or their components (e.g., metal sensitivity).
  • ✕ Participation in the treatment period of another clinical trial during the clinical investigation.
  • ✕ Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.44. Examples include any subject "with lack of or loss of autonomy due to immaturity or through mental disability, persons in nursing homes, children, impoverished

Where it's recruiting

California

Rancho Mirage

Ohio

Columbus

Source: ClinicalTrials.gov · NCT07764614 · last updated 2026-10-23

Tornier Perform™ Reversed Monopost Study · TrialPath